Similarly, in pancreatic ductal adenocarcinoma, iCAFs‐derived CXCL12 mediates immune exclusion by preventing T cell infiltration, contributing to immune checkpoint inhibitor resistance [44]. This evidence concerns the gene CXCL12 and pancreatic ductal adenocarcinoma.